Q4 2018 Aurinia Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to the Aurinia Fourth Quarter and Full Year 2018 Financial Results and Operational Highlights Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to Dr. Glenn Schulman. Thank you. Please begin.
Thanks, Royanne. Good afternoon, everyone. Welcome to Aurinia's Q4, Year-End 2018 Earnings Call and General Business Update. Joining me on the call today from Aurinia are Dr. Richard Glickman, Chief Executive Officer; Dennis Bourgeault, Chief Financial Officer; Dr. Neil Solomons, Chief Medical Officer; Mr. Michael Martin, Chief Operating Officer.
This afternoon, we issued a press release detailing fourth quarter, year-end 2018 financial results and our corporate update for the year. The press release and associated financial statement package is available on our website at www.auriniapharma.com and informs 40-F and 6-K filed earlier on EDGAR and SEDAR. I'd like to remind
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |